Geoffrey Ling, MD/PhD

Executive Advisor Dr. Geoffrey Ling is a neurologist, pharmacologist, and retired U.S. Army colonel with over two decades of leadership in medical innovation and biotechnology. As the founding director of the Biological Technologies Office at DARPA, he led pioneering programs including Revolutionizing Prosthetics—which developed the first FDA-approved brain-controlled prosthetic arm—PREVENT, which improved understanding and care of blast-related traumatic brain injury (TBI), and Battlefield Medicine, which enabled point-of-care drug manufacturing and led to the founding of On Demand Pharmaceuticals.

He also served as Assistant Director for Medical Innovation at the White House Office of Science and Technology Policy under President Obama, where he helped launch the BRAIN Initiative and national efforts to combat antibiotic resistance.

Dr. Ling deployed to Afghanistan and Iraq as a critical care physician and served on the Joint Chiefs of Staff “Gray Team” to improve TBI care in combat zones. He is currently the CEO and co-founder of On Demand Pharmaceuticals and serves as a professor of neurology, neurosurgery, and anesthesiology at Johns Hopkins University. He has served on multiple NIH and VA advisory councils, shaping national research and health policy.